Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy.

Wei Yen ChanJenny H LeeAshleigh StewartRussell J DiefenbachMaria GonzalezAlexander M MenziesChristian BlankRichard A ScolyerGeorgina V LongHelen Rizos

Published in: Journal of experimental & clinical cancer research : CR (2024)

Post-surgery ctDNA positivity and zero-conversion are highly predictive of recurrence, offering a window for personalised modification of adjuvant therapy.

Keyphrases

circulating tumor
free survival
minimally invasive
rectal cancer
coronary artery bypass
lymph node
cell free
locally advanced
single molecule
circulating tumor cells
acute coronary syndrome
atrial fibrillation